Moreover, the in vivo experiment in the present study for the first time showed that MDM2 inhibitor JNJ-165 alleviated the development of atherosclerosis and reversed mitochondrial damage and related inflammation in this process, along with the increased RXRβ protein expression in the aorta of mice. Here, MDM2 is linked to atherosclerosis.